Framework demonstrates improved drug synergy prediction in cancer therapy, suggesting new directions for treatment.
Motivation Drug combinations are crucial for overcoming resistance in cancer therapy. Although deep learning has achieved strong performance in synergy prediction, existing models often treat cell-specific features and paired drugs as a static background and fail to capture how the specific cell-drug environment dynamically modulates drug representations, thereby hindering the modeling of environment-specific synergistic effects. Results We propose Env-Syn, a framework for modeling drug-drug-cell interactions through Environment-Conditioned Feature Modulation, which incorporates a Residual Feature-wise Linear Modulation (R-FiLM) module to perform precise affine transformations on drug representations conditioned on paired drugs and cellular environments. Benchmark evaluations show that Env-Syn consistently outperforms state-of-the-art methods. Notably, the model exhibits exceptional generalization performance in rigorous inductive scenarios. It maintains high predictive accuracy for unseen drugs with AUROC and AUPRC exceeding 0.81 in the Leave-drug-out setting, and further demonstrates strong cross-dataset reliability by surpassing a recall of 0.7 on independent test set. Furthermore, among 15 novel predicted drug combinations, eight are directly supported by literature evidence. These results demonstrate that Env-Syn is an effective computational tool for drug synergy discovery. Availability The source code is available at https://github.com/AnQi-87/Env-Syn. Supplementary information Supplementary data is available at Bioinformatics online.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: